Abstract
Meth A sarcoma, when inoculated in the skin, grew progressively in hybrid CB6 Fl(Balb/c×C57B1/6) mice. When water-soluble aminated β1-3D-glucan (AG) was injected intravenously or intraperitoneally on day 7 of tumor growth, the tumors underwent complete regression. When the injection was performed on day 3 there was regression of tumors in only about half of the cases. When the injection was performed on day 14 there was no apparent effect on tumor growth. Tumors in thymectonized animals did not appear to respond to treatment with AG on day 7. The relatively simple chemistry and low toxicity of AG, together with its solubility in biological fluids, makes it a promising tool in experimental—and possibly clinical—tumor therapy.
This is a preview of subscription content, log in via an institution to check access.
Abbreviations
- AG:
-
aminated glucan
References
Seljelid, R.,Acta Medica. Scand. (in press 1986).
Bøgwald, J., Hoffman, J., and Seljelid, R. (1986)Carbohydrate Res. 148:101–107.
Østerud, B., and Bjørklid, E. (1982).Scand. J. Immunol. 29:175–184.
Shear, M. J. (1943).J. Natl. Cancer Inst. 4:461–476.
North, R. J. (1984).Cancer Immunol. Immunother 18:75–79.
Di Luzio, N. R. (1985). In:Springer Seminar in Immunopathology (Hadden, J. W., and Spreafico, F. Eds.) Springer Verlag Inc., New York, Vol. 8, pp. 387–400.
Seljelid, R., Bøgwald, J., Hoffman, J., and Larm, O. (1984).Immunopharmacology 7:69–73.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Seljelid, R. A water-soluble aminatedβ1-3D-glucan derivative causes regression of solid tumors in mice. Biosci Rep 6, 845–851 (1986). https://doi.org/10.1007/BF01117108
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01117108